Cysteamine broadly improves the anti-plasmodial activity of artemisinins against murine blood stage and cerebral malaria
Reference:
Malaria Journal 2016 15:260, 6 May 2016
These findings indicate that inclusion of Cys in current formulations of ACT, or its use as adjunct therapy could improve the anti-plasmodial activity of artemisinin, decrease mortality in cerebral malaria patients, and prevent or delay the development and spread of artemisinin resistance.
Medical Treatment:
